Skip to main content

Table 3 Compares between study groups after cross over

From: Daily intake of 30 mg duloxetine is effective in decreasing premature ejaculation severity: a prospective randomized placebo-controlled cross over clinical trial

 

Group

P value

A

B

Median

Minimum

Maximum

Median

Minimum

Maximum

AIPE Baselinea

19

9

30

19.5

8

30

0.41d

IELT baseline (Sec)b

60

30

120

60

30

120

0.577d

Male SQOL baselinec

20

15

30

21

16

33

0.294d

AIPE after duloxetinea

26

9

34

26

14

34

0.626d

IELT after duloxetine (Sec)b

180

30

240

240

120

240

0.283d

Male SQOL after duloxetinec

45

18

55

40

30

55

0.029d

AIPE after placeboa

19

9

30

19.5

8

30

0.995d

IELT after placebo (Sec)b

60

30

160

60

30

120

0.292d

Male SQOL after placeboc

21

17

30

21

16

30

0.617d

  1. aAIPE The Arabic index of premature ejaculation
  2. bIELT Intravaginal ejaculatory latency time
  3. cMale SQOL (sexual quality of life questionnaire- male version) after cross over
  4. dP value was calculated using Mann Whitney U test